Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Ana G. Pinczuk, who serves as President of Product & Technology at SentinelOne, Inc. (NYSE:S), has completed a mandatory stock transaction involving the sale of 16,042 shares of the company's Class A Common Stock. The transaction, executed on July 6, 2026, was necessitated by tax withholding requirements tied to the vesting and settlement of Restri…
Natera, Inc. (NASDAQ:NTRA) Chief Legal Officer and Secretary Daniel Rabinowitz executed a significant sale of company shares on July 1, 2026. The transaction, conducted under a pre-existing Rule 10b5-1 trading plan adopted in December 2025, involved the disposal of 16,800 shares. This sale took place while Natera's stock was trading near its 52-wee…
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ: NTRA), executed a series of stock sales totaling $818,710 on July 1, 2026. The transaction occurred as Natera's shares traded near their 52-week high of $288, reflecting a 79% gain over the previous year. According to InvestingPro analysis, the stock is currently positio…
Summit Midstream Corp. executive James David Johnston recently executed a sale of 2,600 shares under a Rule 10b5-1 trading plan, a standard mechanism used by corporate insiders to manage equity positions while maintaining regulatory compliance. The transaction highlights ongoing executive stock management within the midstream energy sector, even as…
Entities linked to Sardar Biglari, a significant shareholder in El Pollo Loco Holdings, Inc., executed a series of stock sales totaling approximately $2.45 million through The Lion Fund II, L.P. in early July. The transactions, reported via SEC Form 4 filings, took place near the company’s 52-week high, coinciding with strong first-quarter fiscal 2…
Nancy JoAnn Johnson, Senior Vice President of Sales and Commercial Operations at BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 801 shares of the company’s Class A Common Stock on July 1, 2026. The transaction, valued at $100,055, was conducted at prices between $124.900 and $124.940 per share under a Rule 10b5-1 trading plan adopted on March…
Mark Streams, who serves as executive vice chairman and chief legal officer at StubHub Holdings, Inc., has completed a series of transactions involving the company's Class A Common Stock. The executive sold approximately $410,428 worth of shares in early July 2026 while simultaneously acquiring 155,520 restricted stock units (RSUs) granted at no co…
Nayaab Islam, President and Chief Product Officer of StubHub Holdings, Inc., executed a series of equity sales totaling approximately $741,470 in early July 2026. The transactions, conducted under a Rule 10b5-1 trading plan established in March 2026, involved the sale of 56,899 shares of Class A Common Stock. This divestment occurs against a backdr…
ImmunityBio, Inc. (NASDAQ:IBRX) director Cheryl Cohen executed a series of transactions on July 2, 2026, involving the sale of common stock and the exercise of stock options. The sales were conducted under a Rule 10b5-1 trading plan, while the option exercises were carried out at a fixed exercise price. These transactions follow a significant perio…
Snowflake Inc. director Benoit Dageville executed a substantial reduction in his equity position, offloading approximately $48.6 million worth of common stock on July 2, 2026. The transaction, which includes both direct and indirect sales, occurs against a backdrop of significant stock appreciation and ongoing valuation debates regarding the cloud …
Mark Haymond Robinson, serving as General Counsel and Secretary for GameStop Corp., executed a series of share sales between July 1 and July 6, 2026. These transactions involved the liquidation of 10,040 shares, generating proceeds totaling $248,028. The sales were facilitated through two distinct mechanisms: one transaction triggered by restricted…
Christian Kleinerman, Executive Vice President of Product Management at Snowflake Inc. (NASDAQ: SNOW), completed a stock transaction on July 1, 2026, selling 2,500 shares valued at $646,400. The sale was executed at $258.56 per share under a 10b5-1 trading plan established on December 26, 2025. Following the transaction, Kleinerman retains signific…
Daniel Moore, serving as the Principal Financial Officer and Principal Accounting Officer for GameStop Corp., executed a sale of 7,085 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at $158,562, was necessitated by withholding taxes related to the vesting of restricted stock units. This sale follows a period o…
Lawrence Philippa, Freshworks Inc.'s Chief Accounting Officer, executed a $35,151 sale of Class A Common Stock on July 6, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction occurred as the stock trades near $10.17, with analysts citing undervaluation and AI-driven growth potential. Concurrently, Freshworks unveiled its Freddy A…
Snowflake Inc. (NASDAQ: SNOW) director Teresa Briggs has executed the sale of company shares totaling $175,098, according to recent Securities and Exchange Commission (SEC) filings. The transactions, conducted under a pre-arranged 10b5-1 trading plan adopted in March 2026, occurred on July 2 and July 6, 2026. This insider activity takes place again…
Palisade Bio, Inc. (NASDAQ: PALI) director Robert Baltera Jr. recently increased his ownership stake in the biotechnology company through a series of stock purchases. The acquisition coincides with the company receiving FDA clearance to initiate a Phase 2 clinical trial for its investigational drug, PALI-2108, aimed at treating ulcerative colitis.
Sight Sciences, Inc. (NASDAQ:SGHT) Chief Technology Officer David Badawi completed a transaction on July 6, 2026, selling 7,418 shares of common stock valued at $40,858. The sale was facilitated through a pre-arranged Rule 10b5-1 trading plan to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). Following the transact…
Brenton Taylor, Sight Sciences' Executive Vice President of Operations and R&D, executed a sale of company shares on July 1, 2026, to cover tax liabilities related to restricted stock unit vesting. The transaction involved 2,829 shares at a weighted average price of $5.42, reducing his direct holdings but leaving him with a significant remaining st…
Jeremy B. Hayden, Sight Sciences, Inc.'s (NASDAQ:SGHT) Chief Legal Officer, executed a sale of 12,733 shares on July 6, 2026, totaling $70,133. The transaction, designated to cover tax liabilities from restricted stock unit vesting, leaves Hayden with a direct holding of 357,037 shares. This sale occurs against a backdrop of mixed first-quarter 202…
Sight Sciences, Inc. (NASDAQ: SGHT) Chief Financial Officer James Rodberg executed a sale of 6,902 common shares on July 2, 2026, totaling $36,994. The transaction, driven by tax obligations from restricted stock unit vesting, leaves Rodberg with a direct holding of 224,037 shares. This corporate activity unfolds against a backdrop of mixed first-q…
Andrew Guggenhime, who serves as both President and Chief Financial Officer at Vaxcyte, Inc. (NASDAQ: PCVX), has executed the sale of 10,000 shares of the company's common stock. The transactions, which totaled approximately $572,836, were carried out on July 6, 2026, under the parameters of a Rule 10b5-1 trading plan established earlier in the yea…
Sight Sciences President and CEO Paul Badawi executed a sale of 28,684 shares on July 1, 2026, generating $155,467 to address tax liabilities associated with restricted stock unit vesting. The transaction occurs amid the company's Q1 2026 financial results, which showed revenue growth but continued losses. Badawi retains significant ownership, hold…
Alison Bauerlein, Chief Operating Officer of Sight Sciences, Inc. (NASDAQ: SGHT), executed a sale of 24,184 shares on July 2, 2026, generating approximately $129,626 in proceeds. The transaction was structured to cover tax liabilities tied to the vesting of restricted stock units. Following the sale, Bauerlein retains direct ownership of 664,709 sh…
Bruce K. Posey, the Chief Legal Officer at Qualys, Inc. (NASDAQ:QLYS), executed a sale of 1,000 shares on July 6, 2026, totaling $155,000. This transaction follows a pre-arranged Rule 10b5-1 trading plan. The sale occurs as QLYS stock trades near its 52-week high, reflecting a complex landscape of analyst opinions and corporate developments in the …
Francis Lo, Chief People Officer at Adaptive Biotechnologies Corp (NASDAQ:ADPT), executed a series of transactions involving the sale and acquisition of company stock in early July 2026. The executive's dispositions were carried out under a pre-established Rule 10b5-1 trading plan, occurring as the stock trades near its 52-week high. Concurrently, …
